UK Bans Puberty Blockers for Under-18s with Gender Dysphoria
Following expert medical advice, the UK government has implemented an indefinite ban on puberty blockers for under-18s with gender dysphoria, except within clinical trials. This decision, supported by the Commission on Human Medicines citing unacceptable safety risks, makes permanent the emergency measures initially introduced in May. The ban applies UK-wide, following consultation with devolved administrations, and affects new patients only; existing patients will continue treatment. A planned clinical trial aims to establish a clearer evidence base for the medication’s use.
John Q. Hosedrinker